TransMedics Group, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q2 2024 | 1 | $0.21 | $0.21 | $0.21 |
| Q3 2024 | 2 | $0.29 | $0.29 | $0.29 |
| Q4 2024 | 6 | $0.11 | $0.24 | $0.17 |
| Q1 2025 | 5 | $0.24 | $0.33 | $0.29 |
| Q2 2025 | 4 | $0.42 | $0.46 | $0.44 |
| Q3 2025 | 4 | $0.39 | $0.43 | $0.41 |
| Q4 2025 | 4 | $0.41 | $0.45 | $0.43 |
| Q1 2026 | 3 | $0.49 | $0.54 | $0.51 |
| Q2 2026 | 3 | $0.58 | $0.64 | $0.61 |
| Q3 2026 | 3 | $0.52 | $0.57 | $0.55 |
| Q4 2026 | 3 | $0.60 | $0.66 | $0.63 |
TransMedics Group, Inc. Earnings Date And Information
TransMedics Group, Inc. last posted its earnings results on Monday, October 28th, 2024. The company reported $0.12 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by $0.17. The company had revenue of 108.76 M for the quarter and had revenue of 241.62 M for the year. TransMedics Group, Inc. has generated $-1 earnings per share over the last year ($-0.77 diluted earnings per share) and currently has a price-to-earnings ratio of 78.88. TransMedics Group, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based on prior year's report dates.
TransMedics Group, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/29/2024 | Q3 2024 | $0.13 | $115.00 M | $108.76 M | ||
| 08/01/2024 | Q2 2024 | $0.37 | $98.84 M | $114.31 M | ||
| 05/02/2024 | Q1 2024 | $0.37 | $96.85 M | |||
| 02/27/2024 | Q4 2023 | $0.12 | $81.17 M | |||
| 11/08/2023 | Q3 2023 | -$0.78 | $49.19 M | $66.43 M | ||
| 08/04/2023 | Q2 2023 | -$0.03 | $42.42 M | $52.47 M | ||
| 05/04/2023 | Q1 2023 | -$0.08 | $41.55 M | |||
| 02/27/2023 | Q4 2022 | -$0.21 | $31.38 M | |||
| 11/04/2022 | Q3 2022 | -$0.25 | $18.88 M | $25.68 M | ||
| 08/03/2022 | Q2 2022 | -$0.41 | $16.27 M | $20.52 M | ||
| 05/05/2022 | Q1 2022 | -$0.38 | $15.88 M | |||
| 03/01/2022 | Q4 2021 | -$0.46 | $9.67 M | |||
| 11/09/2021 | Q3 2021 | -$0.32 | -$0.47 | -0.15 | $6.34 M | $5.37 M |
| 08/06/2021 | Q2 2021 | -$0.39 | $7.42 M | $8.17 M | ||
| 05/07/2021 | Q1 2021 | -$0.29 | $7.05 M | |||
| 03/11/2021 | Q4 2020 | -$0.23 | $7.63 M | |||
| 11/06/2020 | Q3 2020 | -$0.19 | $5.55 M | $7.09 M | ||
| 08/07/2020 | Q2 2020 | -$0.36 | $2.75 M | $3.39 M | ||
| 05/06/2020 | Q1 2020 | -$0.39 | -$0.42 | -0.03 | $7.53 M | |
| 03/17/2020 | Q4 2019 | -$0.43 | $6.06 M |
TransMedics Group, Inc. Earnings: Frequently Asked Questions
-
When is TransMedics Group, Inc.'s earnings date?
TransMedics Group, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based off last year's report dates.
-
How can I listen to TransMedics Group, Inc.'s earnings conference call?
The conference call for TransMedics Group, Inc.'s latest earnings report can be listened to online.
-
How can I read TransMedics Group, Inc.'s conference call transcript?
The conference call transcript for TransMedics Group, Inc.'s latest earnings report can be read online.
-
How much revenue does TransMedics Group, Inc. generate each year?
TransMedics Group, Inc. (:TMDX) has a recorded annual revenue of $241.62 M.
-
How much profit does TransMedics Group, Inc. generate each year?
TransMedics Group, Inc. (:TMDX) has a recorded net income of $241.62 M. TransMedics Group, Inc. has generated $-0.77 earnings per share over the last four quarters.
-
What is TransMedics Group, Inc.'s price-to-earnings ratio?
TransMedics Group, Inc. (:TMDX) has a price-to-earnings ratio of 78.88 and price/earnings-to-growth ratio is 0.07.
